PreprintAll rights reservedmedRxiv
PBPK Model-Based Prediction of Optimal Rosuvastatin Dosing with Concomitant Ticagrelor in Elderly Patients Considering ABCG2 Genetic Variant.
- 1Mahidol Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University
Related
- Severe Rhabdomyolysis and Acute Kidney Injury Following Rosuvastatin Reinitiation During Ticagrelor Therapy: A Case Report and Literature Review
- Ticagrelor-Induced Bradyarrhythmias in Acute Coronary Syndrome: A Case Series of Three Patients.
- Association of ticagrelor versus clopidogrel with in-hospital early outcomes in elderly patients with acute myocardial infarction complicated by cardiogenic shock: findings from CCC-ACS project
- Outcomes of Surgical Versus Transcatheter Mitral Valve Repair or Replacement in Patients With Myocardial Infarction and Concomitant Mitral Regurgitation: A Retrospective Analysis of Real-World Data
- Research on expressway traffic accident risk prediction method considering Spatio-Temporal effects
BibTeX
@misc{nguyen2026pbpk,
title = {{PBPK Model-Based Prediction of Optimal Rosuvastatin Dosing with Concomitant Ticagrelor in Elderly Patients Considering ABCG2 Genetic Variant.}},
author = {D. H. Nguyen and H. T. V. Pham and J. Ding and J. Tarning},
howpublished = {medRxiv},
year = {2026},
month = oct,
doi = {10.64898/2026.10.16.26365646},
url = {https://www.medrxiv.org/content/10.64898/2026.10.16.26365646v1},
}
RIS
TY - UNPB
TI - PBPK Model-Based Prediction of Optimal Rosuvastatin Dosing with Concomitant Ticagrelor in Elderly Patients Considering ABCG2 Genetic Variant.
AU - D. H. Nguyen
AU - H. T. V. Pham
AU - J. Ding
AU - J. Tarning
PY - 2026
DA - 2026/10/16
PB - medRxiv
DO - 10.64898/2026.10.16.26365646
UR - https://www.medrxiv.org/content/10.64898/2026.10.16.26365646v1
ER -